Similar articles

• Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.

  Yeo W, Mo FK, Chan SL, Leung NW, Hui P, Lam WY, Mok TS, Lam KC, Ho WM, Koh J, Tang JW, Chan AT, Chan PK. Yeo W, et al. Hepatology. 2007 Jun;45(6):1382-9. doi: 10.1002/hep.21572. Hepatology. 2007. PMID: 17539025 Clinical Trial.
• Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.

  Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Alacacioglu A, et al. Jpn J Clin Oncol. 2008 Oct;38(10):683-8. doi: 10.1093/jjco/hyn082. Epub 2008 Aug 27. Jpn J Clin Oncol. 2008. PMID: 18753360
• Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

  Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G. Yin J, et al. Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12. Carcinogenesis. 2008. PMID: 18192693
• Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.

  Hoshida Y. Hoshida Y. J Hepatol. 2009 Nov;51(5):842-4. doi: 10.1016/j.jhep.2009.08.003. Epub 2009 Sep 2. J Hepatol. 2009. PMID: 19748698 Review. No abstract available.
• Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.

  Sherman M. Sherman M. Cleve Clin J Med. 2009 May;76 Suppl 3:S6-9. doi: 10.3949/ccjm.76.s3.02. Cleve Clin J Med. 2009. PMID: 19465708 Review.